Range
5.49 - 5.93
Vol / Avg.
514.8K/860.5K
Div / Yield
-
52 Wk
0.25 - 8.71
Mkt Cap
35.9M
Payout Ratio
-
Open
5.56
P/E
49.27
EPS
-0.29
Shares
6.3M
Outstanding
6.3M
Total Float
-
Benzinga - May 13, 2021, 5:13PM
Benzinga - May 13, 2021, 10:07AM
Benzinga - May 13, 2021, 10:01AM
Benzinga - Apr 16, 2021, 11:17AM
Benzinga - Apr 8, 2021, 10:25AM
Benzinga - Apr 1, 2021, 9:26AM
Benzinga - Apr 1, 2021, 9:01AM
Benzinga - Mar 23, 2021, 4:31PM
Benzinga - Mar 4, 2021, 9:57AM
load more
Sector: Health Care.Industry: Biotechnology
Geovax Labs Inc is US-based clinical-stage biotechnology company. It is engaged in developing immunotherapies and vaccines against cancers and infectious diseases using a novel patented Modified Vaccinia Ankara-Virus Like Particle (GV-MVA-VLP) vector vaccine platform. The development programs of the company focused on preventive vaccines against Human Immunodeficiency Virus (HIV), Zika Virus, hemorrhagic fever viruses, and malaria, as well as therapeutic vaccines for chronic Hepatitis B infections and cancers. The product pipeline includes HIV-Clade B Preventive Vaccine, HIV-Clade B Immunotherapy, Hemorrhagic Fever Vaccines, Zika Vaccine, Malaria vaccine, and Cancer Immunotherapy.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS-0.290
REV110.417K
Q4 2020Est.ActualSurprise
EPS-0.970
REV333.000K250.963K-82.037K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
GOVXGeovax Labs4.98%35.9M

Geovax Labs Frequently Asked Questions

Q

How do I buy Geovax Labs (GOVX) stock?

A

You can purchase shares of Geovax Labs (NASDAQ: GOVX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Geovax Labs's (GOVX) competitors?

A

Other companies in Geovax Labs’s space includes: Panbela Therapeutics (NASDAQ:PBLA), Immuron (NASDAQ:IMRN), Synaptogenix (NASDAQ:SNPX), Histogen (NASDAQ:HSTO) and Midatech Pharma (NASDAQ:MTP).

Q

What is the target price for Geovax Labs (GOVX) stock?

A

The latest price target for Geovax Labs (NASDAQ: GOVX) was reported by Maxim Group on November 19, 2020. The analyst firm set a price target for 8.00 expecting GOVX to rise to within 12 months (a possible 40.60% upside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Geovax Labs (GOVX)?

A

The stock price for Geovax Labs (NASDAQ: GOVX) is $5.69 last updated Today at 7:20:46 PM.

Q

Does Geovax Labs (GOVX) pay a dividend?

A

There are no upcoming dividends for Geovax Labs.

Q

When is Geovax Labs (NASDAQ:GOVX) reporting earnings?

A
Geovax Labs’s Q2 earnings are confirmed for after-market on August 5, 2021.
Q

Is Geovax Labs (GOVX) going to split?

A

There is no upcoming split for Geovax Labs.

Q

What sector and industry does Geovax Labs (GOVX) operate in?

A

Geovax Labs is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.